中医治疗血液病名家学术观点撷菁ⅣOA北大核心CSTPCD

The China Association of Chinese Medicine Blood Disease Branch and Hematological Diseases'Innovative Research and Transformation Platform summarized the academic thoughts and experiences of clinical diagnosis and treatment from five professors to better inherit and develop the academic thoughts of prestigious traditional Chinese medicine(TCM)practitioners.These professors include TAO Shuchun,GU Zhendong,WU Zhikui,YU Rongxi,and ZHOU Zhongying.Professor TAO Shuchun researches the pathogenesis,combines the diagnosis and treatment of zang-fu viscera and parts,and attaches great significance to activating blood and resolving stasis.Professor GU Zhendong established a dialectical system for acute leukemia and summarized the laws of pulse syndrome,advocating combining TCM and Western medicine to treat this disease.Professor WU Zhikui proposed the pathogenesis and treatment of thalassemia and was the first to apply Yisui Shengxue Granules to treat this disease and achieved good results.Professor YU Rongxi proposed a TCM syndrome differentiation system for leukemia and integrated TCM and Western medicine to treat this disease.Professor ZHOU Zhongying improved the system for syndrome differentiation and treatment in internal medicine of TCM,established the theory of TCM pathogenesis and syndrome differentiation,and applied the theories of"stasis heat"and"cancer toxin"to treat blood disease.The purpose of this initiative is to cultivate and improve the capacity of reserve talents in the hematology of TCM to promote discipline construction.Simultaneously,this initiative provides extremely valuable insights for the inheritance and development of TCM.